Market Access Views & Analysis

Views & Analysis

Market Access

Transformative trends with real-world data from early access...

The complex and changing needs of patients with life-threatening conditions has led many health authorities to introduce early access programmes.

Market Access

True innovation in life sciences is only possible through a ...

Many of the biggest life sciences breakthroughs are the result of European research.

Market Access

Six takeaways from JP Morgan 2024

With another JP Morgan in the rearview mirror, it’s time to take stock of the announcements, the presentations, and, above all, the vibes.

Market Access

Promoting value-added medicines and renovating old medicines...

In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.

Views & Analysis

JPM: Four ways FDA is seeking to buoy gene therapy

On the outskirts of the JP Morgan Healthcare Conference today, FDA's Dr Peter Marks discussed how to get more gene therapies approved in 2024.

Market Access

The race to develop innovative products and supply chain sol...

In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and

Transformative trends with real-world data from early access...

True innovation in life sciences is only possible through a ...

Six takeaways from JP Morgan 2024

Promoting value-added medicines and renovating old medicines...

JPM: Four ways FDA is seeking to buoy gene therapy

The race to develop innovative products and supply chain sol...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks